DPYD and Hepatic steatosis: However, a body of preclinical work demonstrates uridine levels influence hepatic lipid accumulation, providing scientific rationale for DPYD inhibition as a significant driver of liver lipid levels and a potential clinical target for mitigating hepatic steatosis.